<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001663</url>
  </required_header>
  <id_info>
    <org_study_id>970053</org_study_id>
    <secondary_id>97-N-0053</secondary_id>
    <nct_id>NCT00001663</nct_id>
  </id_info>
  <brief_title>Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation</brief_title>
  <official_title>Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      Myoclonus is a condition related to epilepsy of involuntary twitching or jerking of the&#xD;
      limbs.&#xD;
&#xD;
      The purpose of this study is to determine if stimulation of the brain with magnetic pulses&#xD;
      can decrease myoclonus. Researchers believe that this may be possible because in studies on&#xD;
      normal volunteers, magnetic stimulation made areas of the brain difficult to activate for&#xD;
      several minutes. In addition, early studies on patients with myoclonus have shown magnetic&#xD;
      stimulation to be effective at decreasing involuntary movements.&#xD;
&#xD;
      Transcranial Magnetic Stimulation (TMS) is a non-invasive technique that can be used to&#xD;
      stimulate brain activity and gather information about brain function. It is very useful when&#xD;
      studying the areas of the brain and spinal cord related to motor activity (motor cortex and&#xD;
      corticospinal tract). Repetitive transcranial magnetic stimulation (rTMS) involves the&#xD;
      placement of coil of wire (electromagnet) on the patient's scalp and rapidly turning on and&#xD;
      off the electrical current. The changing magnetic field produces weak electrical currents in&#xD;
      the brain near the coil. This permits non-invasive, relatively localized stimulation of the&#xD;
      surface of the brain (cerebral cortex). The effect of magnetic stimulation varies, depending&#xD;
      upon the location, intensity and frequency of the magnetic pulses.&#xD;
&#xD;
      Researchers plan to use rTMS for 10 days on patients participating in the study. The 10 day&#xD;
      period will be broken into 5 days of active repetitive magnetic stimulation and 5 days of&#xD;
      placebo &quot;ineffective&quot; stimulation. At the end of the 10 day period, if the results show that&#xD;
      rTMS was beneficial, patients may undergo an additional 5 days of active rTMS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Repetitive transcranial magnetic stimulation (rTMS) at frequencies in the single Hz range&#xD;
      causes a decrease in the excitability of the primary motor cortex and there is preliminary&#xD;
      evidence that it can suppress abnormal excess cortical activity. We plan to test 1 Hz rTMS as&#xD;
      treatment for cortical myoclonus.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 1997</start_date>
  <completion_date>January 2002</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <enrollment>10</enrollment>
  <condition>Movement Disorder</condition>
  <condition>Myoclonus</condition>
  <condition>Nervous System Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magstim Super Rapid Stimulator</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Age 5 to 90 with severe cortical myoclonus.&#xD;
&#xD;
        No intracranial metal hardware (excluding dental fillings), pacemakers, indwelling&#xD;
        medication pumps, cochlear implants, intracardiac lines, significant intracranial masses or&#xD;
        increased intracranial pressure.&#xD;
&#xD;
        Subject must not be pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Institute of Neurological Disorders and Stroke (NINDS)</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology. 1992 Oct;42(10):1951-9. doi: 10.1212/wnl.42.10.1951.</citation>
    <PMID>1407578</PMID>
  </reference>
  <reference>
    <citation>Inghilleri M, Berardelli A, Cruccu G, Manfredi M. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol. 1993 Jul;466:521-34.</citation>
    <PMID>8410704</PMID>
  </reference>
  <reference>
    <citation>Fuhr P, Agostino R, Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol. 1991 Aug;81(4):257-62. doi: 10.1016/0168-5597(91)90011-l.</citation>
    <PMID>1714819</PMID>
  </reference>
  <verification_date>January 2002</verification_date>
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>November 3, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 1999</study_first_posted>
  <last_update_submitted>March 3, 2008</last_update_submitted>
  <last_update_submitted_qc>March 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2008</last_update_posted>
  <keyword>Neurological Disorders</keyword>
  <keyword>Movement Disorders</keyword>
  <keyword>Physiology</keyword>
  <keyword>Noninvasive</keyword>
  <keyword>Brain Stimulation</keyword>
  <keyword>Cortical Myoclonus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Movement Disorders</mesh_term>
    <mesh_term>Myoclonus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

